|
|
||||||||
The Journal of Immunology, Vol 130, Issue 6 2499-2501, Copyright © 1983 by American Association of Immunologists
COMMUNICATIONS |
CG Orosz, DC Roopenian and FH Bach
Prolonged contact with nanomole to micromole concentrations of the tumor promoter phorbol myristate acetate causes a significant reduction in the lytic activity of cloned cytolytic T cells. Diminished lysis is apparent even in the presence of agglutinating lectins. PMA does not exert this effect by minimizing clone viability. In fact, these concentrations of PMA cause significant potentiation of antigen-driven proliferation for many of these same clones. The PMA-mediated loss of cytolysis is reversible. Although contact with antigen does not induce or enhance reexpression of cytolysis, PMA-treated cytolytic T cell clones display normal cytolytic activity after contact with lymphokines.
This article has been cited by other articles:
![]() |
X. W. Meng, M. P. Heldebrant, and S. H. Kaufmann Phorbol 12-myristate 13-Acetate Inhibits Death Receptor-mediated Apoptosis in Jurkat Cells by Disrupting Recruitment of Fas-associated Polypeptide with Death Domain J. Biol. Chem., January 25, 2002; 277(5): 3776 - 3783. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |